L Guidi

Summary

Affiliation: Catholic University
Country: Italy

Publications

  1. pmc Treatment of Crohn's disease with colony-stimulating factors: An overview
    Luisa Guidi
    Department of Internal Medicine, Operative Unit of Gastroenterology and
    Ther Clin Risk Manag 4:927-34. 2008
  2. pmc Update on the management of inflammatory bowel disease: specific role of adalimumab
    Luisa Guidi
    Internal Medicine and Gastroenterology, Complesso Integrato Columbus, Universita Cattolica del Sacro Cuore, Rome, Italy
    Clin Exp Gastroenterol 4:163-72. 2011
  3. pmc FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents
    Luisa Guidi
    Department of Internal Medicine, Inflammatory Bowel Disease Unit, Complesso Integrato Columbus, Catholic University, Largo Gemelli 8, 00168 Rome, Italy
    Biomed Res Int 2013:286368. 2013
  4. ncbi Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients
    Gianluca Andrisani
    Department of Gastroenterology CIC, Catholic University, Via Moscati 31 33, 00168 Rome, Italy
    J Gastrointestin Liver Dis 22:21-5. 2013
  5. ncbi Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment
    L Guidi
    Istituto di Medicina Interna, Universita Cattolica del Sacro Cuore, Roma, Italy
    Int J Immunopathol Pharmacol 18:155-64. 2005
  6. ncbi New biological agents for the treatment of the "high risk" IBD patients
    L Guidi
    U O C Medicina Interna e Gastroenterologia, Complesso Integrato Columbus, Universita Cattolica del Sacro Cuore, Roma, Italy
    Eur Rev Med Pharmacol Sci 14:342-6. 2010
  7. ncbi Interleukin-6 release in the hepatic blood outflow during normothermic liver ischaemia in humans
    L Guidi
    Institute of Internal Medicine and Geriatrics, Catholic University of the Sacred Heart, Largo A Gemelli 8, 00168 Rome, Italy
    Dig Liver Dis 35:409-15. 2003
  8. doi Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn's disease with anal endosonographic monitoring: a single-centre experience
    L Guidi
    Dipartimento di Medicina Interna Scienze Specialistiche e Dermatologia, Universita Cattolica del Sacro Cuore, Rome, Italy
    Tech Coloproctol 12:111-7. 2008
  9. ncbi Effect of age on DNA binding of the ku protein in irradiated human peripheral blood mononuclear cells (PBMC)
    D Frasca
    Laboratory of Immunology, AMB PRO TOSS, ENEA CR Cassaccia, Rome, Italy
    Exp Gerontol 34:645-58. 1999
  10. ncbi Cell proliferation and ku protein expression in ageing humans
    D Frasca
    Laboratory of Immunology, ENEA CR Casaccia, Rome, Italy
    Mech Ageing Dev 100:197-208. 1998

Collaborators

Detail Information

Publications23

  1. pmc Treatment of Crohn's disease with colony-stimulating factors: An overview
    Luisa Guidi
    Department of Internal Medicine, Operative Unit of Gastroenterology and
    Ther Clin Risk Manag 4:927-34. 2008
    ....
  2. pmc Update on the management of inflammatory bowel disease: specific role of adalimumab
    Luisa Guidi
    Internal Medicine and Gastroenterology, Complesso Integrato Columbus, Universita Cattolica del Sacro Cuore, Rome, Italy
    Clin Exp Gastroenterol 4:163-72. 2011
    ..More data are necessary to clarify the therapeutic role of adalimumab in UC. This review of the literature summarizes available data on the efficacy and safety profile adalimumab in patients with IBD...
  3. pmc FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents
    Luisa Guidi
    Department of Internal Medicine, Inflammatory Bowel Disease Unit, Complesso Integrato Columbus, Catholic University, Largo Gemelli 8, 00168 Rome, Italy
    Biomed Res Int 2013:286368. 2013
    ..Our data suggest the possibility that in IBD patients the treatment with anti-TNFα may affect Treg percentages and that Treg modifications may correlate with clinical response, but differently in early versus late disease...
  4. ncbi Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients
    Gianluca Andrisani
    Department of Gastroenterology CIC, Catholic University, Via Moscati 31 33, 00168 Rome, Italy
    J Gastrointestin Liver Dis 22:21-5. 2013
    ..We compared the performance of Quantiferon-TB Gold (QFT-G) with the tuberculin skin test (TST) for the screening of LTB in a population of inflammatory bowel disease (IBD) patients who were candidates for anti-TNF-α therapy...
  5. ncbi Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment
    L Guidi
    Istituto di Medicina Interna, Universita Cattolica del Sacro Cuore, Roma, Italy
    Int J Immunopathol Pharmacol 18:155-64. 2005
    ..An increase of IkappaB inhibitors levels could be one of the mechanisms by which infliximab decreases NF-kappaB activity and exerts its anti-inflammatory effects...
  6. ncbi New biological agents for the treatment of the "high risk" IBD patients
    L Guidi
    U O C Medicina Interna e Gastroenterologia, Complesso Integrato Columbus, Universita Cattolica del Sacro Cuore, Roma, Italy
    Eur Rev Med Pharmacol Sci 14:342-6. 2010
    ..This association is well known from many years. However, the mechanisms linking chronic inflammation and carcinogenesis are beginning to be elucidated only recently...
  7. ncbi Interleukin-6 release in the hepatic blood outflow during normothermic liver ischaemia in humans
    L Guidi
    Institute of Internal Medicine and Geriatrics, Catholic University of the Sacred Heart, Largo A Gemelli 8, 00168 Rome, Italy
    Dig Liver Dis 35:409-15. 2003
    ..Moreover, they could be potential predictors of the outcome. Modulation of the pattern of cytokine response in the early postsurgery period could represent a new approach to minimise the impact of these procedures...
  8. doi Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn's disease with anal endosonographic monitoring: a single-centre experience
    L Guidi
    Dipartimento di Medicina Interna Scienze Specialistiche e Dermatologia, Universita Cattolica del Sacro Cuore, Rome, Italy
    Tech Coloproctol 12:111-7. 2008
    ..Combined therapy with infliximab and setons with AE monitoring of the response showed high efficacy in the management of patients with CD with complex perianal fistulas...
  9. ncbi Effect of age on DNA binding of the ku protein in irradiated human peripheral blood mononuclear cells (PBMC)
    D Frasca
    Laboratory of Immunology, AMB PRO TOSS, ENEA CR Cassaccia, Rome, Italy
    Exp Gerontol 34:645-58. 1999
    ..This finding was concomitant with the age-related fall of DNA repair in the whole population...
  10. ncbi Cell proliferation and ku protein expression in ageing humans
    D Frasca
    Laboratory of Immunology, ENEA CR Casaccia, Rome, Italy
    Mech Ageing Dev 100:197-208. 1998
    ..These findings suggest that the age-related impairment in DNA repair mechanisms are only in part related to the reduced expression of ku protein able to recognize DNA damage...
  11. ncbi Early atherosclerosis in patients with inflammatory bowel disease
    A Papa
    Department of Internal Medicine, Gastroenterology Unit, Catholic University of Rome, Italy
    Eur Rev Med Pharmacol Sci 10:7-11. 2006
    ....
  12. pmc Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants
    G Andrisani
    Operative Unit of Internal Medicine and Gastroenterology, Complesso Integrato Columbus, Catholic University Sacro Cuore, Roma, Italy
    J Crohns Colitis 7:301-7. 2013
    ..Second and third aims were the safety of pH1N1 vaccine and the effects on IBD clinical activity...
  13. ncbi Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn's disease
    L Guidi
    Dipartimento di Medicina Interna, Scienze Specialistiche e Dermatologia, Catholic University, Rome, Italy
    Eur Rev Med Pharmacol Sci 10:23-6. 2006
    ..v. SonoVue during infliximab therapy might represent an useful, not invasive and relatively low cost imaging modality for the clinical monitoring of activity of small bowel Crohn's disease...
  14. ncbi Increased carotid intima-media thickness in patients with inflammatory bowel disease
    A Papa
    Department of Internal Medicine, Gastroenterology Unit, Catholic University of Rome, Rome, Italy
    Aliment Pharmacol Ther 22:839-46. 2005
    ..Patients with inflammatory bowel disease have an increased risk of thrombotic complications; moreover, mesenteric microvascular thrombosis has been hypothesized as a contributing factor in the pathogenesis of inflammatory bowel disease...
  15. ncbi Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis
    G Andrisani
    Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy
    Reumatismo 65:75-8. 2013
    ..Moreover, Adalimumab is a well-established treatment for RA. Herein, we describe a patient with RA and UC treated successfully with ADA. ..
  16. ncbi Modulation of X-ray-induced damage recognition and repair in ageing human peripheral blood mononuclear cells by an interleukin-6-type cytokine
    D Frasca
    Laboratory of Immunology, AMB PRO TOSS, ENEA C R Casaccia, Via Anguillarese 301, 00060 S Maria di Galeria, Rome, Italy
    Mech Ageing Dev 121:5-19. 2000
    ..However, K-7/D-6 is able to induce unscheduled DNA repair in irradiated PBMC from both young and elderly subjects. These effects of K-7/D-6 are relevant to the mechanisms of the cellular response to DNA damage...
  17. ncbi Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab
    G Andrisani
    IBD Unit, Complesso Integrato Columbus Gemelli Hospital, School of Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Eur Rev Med Pharmacol Sci 17:2831-6. 2013
    ..We report about the effectiveness of ustekinumab in the treatment of both severe scalp psoriasis lesions with alopecia and active Crohn's disease. ..
  18. ncbi Anti-TNF alpha therapy in the management of extraintestinal manifestation of inflammatory bowel disease
    G Andrisani
    Complesso Integrato Columbus, School of Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Eur Rev Med Pharmacol Sci 16:890-901. 2012
    ....
  19. ncbi Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease
    A Papa
    Department of Internal Medicine, Gastroenterology Unit, Catholic University of Rome, A Gemelli University Hospital, Largo A Gemelli 8, 00168 Rome, Italy
    Dig Liver Dis 36:528-32. 2004
    ..Intercellular adhesion molecule 1 gene lies on chromosome 19p13, implicated in determining susceptibility to inflammatory bowel disease. Recently, the polymorphism K469E of intercellular adhesion molecule 1 gene has been identified...
  20. doi A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery
    G Andrisani
    Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy
    J Crohns Colitis 7:421-6. 2013
    ..The surgical approach to PG is reserved to a few selected cases. We report here the case of a patient with ulcerative colitis (UC) and PG localized on the left breast, treated with a simultaneous combined medical and surgical approach...
  21. ncbi The efficacy of chemotherapy with mebendazole in human cystic echinococcosis: long-term follow-up of 52 patients
    C Bartoloni
    Istituto di Clinica Medica Generale e Terapia Medica, , , Rome, Italy
    Ann Trop Med Parasitol 86:249-56. 1992
    ..Treatment of patients with cystic echinococcosis may no longer require surgery...
  22. doi Sonography of the small bowel after oral administration of fluid: an assessment of the diagnostic value of the technique
    P Mirk
    Dipartimento di Bio immagini e Scienze Radiologiche, Universita Cattolica del Sacro Cuore, Largo Gemelli 8, 00168, Roma, Italy
    Radiol Med 117:558-74. 2012
    ..This study was performed to assess the feasibility and possible advantages of bowel sonography after fluid filling of intestinal loops compared with conventional sonography...
  23. ncbi An update on the medical treatment of Crohn's disease
    G Valentini
    Institute of Internal Medicine and Geriatrics, Catholic University of the Sacred Heart, Roma, Italy
    Panminerva Med 45:15-22. 2003
    ..We also will explain the importance of enteral nutrition, whose importance goes over the simple amelioration of nutritional status, especially in childhood CD, where it has shown to be as effective as traditional therapy...